Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thea Pharma
Lexington, Massachusetts, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Thea Pharma, as the US and Irish subsidiary of Laboratoires Théa, commercializes a broad portfolio of preservative-free ophthalmic products for anterior segment and ocular surface conditions, with several products considered standard of care in Europe and growing uptake in the US[1][2][3][4][5].
- Therapeutic areas
- ImmunologyInfectious DiseasesOphthalmology
- Modalities
- Small moleculeDeviceBiologic
- Industry
- Biotech
02
Partnerships
US and Irish healthcare providersOphthalmology clinicsEuropean pharma partnerships via Laboratoires Théa
Beyond the preview
Go deeper on Thea Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thea Pharma.